Concepts (254)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Amyotrophic Lateral Sclerosis | 24 | 2024 | 502 | 4.470 |
Why?
|
| Superoxide Dismutase | 23 | 2022 | 225 | 3.010 |
Why?
|
| Motor Neurons | 12 | 2022 | 212 | 1.980 |
Why?
|
| RNA Interference | 11 | 2011 | 618 | 1.460 |
Why?
|
| Spinal Cord | 11 | 2024 | 204 | 1.400 |
Why?
|
| Transgenes | 4 | 2015 | 187 | 1.300 |
Why?
|
| Mutation | 15 | 2022 | 2604 | 1.280 |
Why?
|
| RNA, Small Interfering | 11 | 2011 | 908 | 1.160 |
Why?
|
| Mice, Transgenic | 19 | 2022 | 1275 | 1.090 |
Why?
|
| Citrullination | 2 | 2024 | 36 | 1.020 |
Why?
|
| Neurodegenerative Diseases | 4 | 2022 | 143 | 0.980 |
Why?
|
| Mice | 36 | 2024 | 10816 | 0.900 |
Why?
|
| Profilins | 4 | 2022 | 45 | 0.840 |
Why?
|
| Mitochondria | 6 | 2006 | 370 | 0.830 |
Why?
|
| Gene Silencing | 6 | 2009 | 394 | 0.790 |
Why?
|
| Animals | 43 | 2024 | 20610 | 0.770 |
Why?
|
| Genetic Predisposition to Disease | 3 | 2016 | 718 | 0.760 |
Why?
|
| Disease Models, Animal | 12 | 2022 | 2179 | 0.750 |
Why?
|
| DNA-Binding Proteins | 3 | 2014 | 1183 | 0.740 |
Why?
|
| Nerve Degeneration | 3 | 2016 | 72 | 0.730 |
Why?
|
| Dependovirus | 5 | 2017 | 708 | 0.640 |
Why?
|
| Genetic Techniques | 2 | 2011 | 37 | 0.590 |
Why?
|
| Superoxide Dismutase-1 | 14 | 2022 | 143 | 0.580 |
Why?
|
| Genetic Therapy | 6 | 2017 | 789 | 0.580 |
Why?
|
| Recombination, Genetic | 3 | 2015 | 245 | 0.570 |
Why?
|
| Neurofilament Proteins | 3 | 2002 | 21 | 0.540 |
Why?
|
| Axonal Transport | 3 | 2022 | 32 | 0.530 |
Why?
|
| Phenotype | 3 | 2016 | 1199 | 0.520 |
Why?
|
| Genetic Association Studies | 1 | 2016 | 120 | 0.500 |
Why?
|
| RNA Polymerase II | 2 | 2006 | 84 | 0.470 |
Why?
|
| Peroxisomes | 2 | 2004 | 10 | 0.440 |
Why?
|
| Vacuoles | 2 | 2004 | 26 | 0.430 |
Why?
|
| Neurons | 3 | 2011 | 923 | 0.430 |
Why?
|
| Drosophila Proteins | 2 | 2022 | 692 | 0.430 |
Why?
|
| Promoter Regions, Genetic | 3 | 2006 | 674 | 0.420 |
Why?
|
| Integrases | 2 | 2011 | 37 | 0.420 |
Why?
|
| Lumbar Vertebrae | 1 | 2015 | 157 | 0.420 |
Why?
|
| Gliosis | 2 | 2024 | 28 | 0.410 |
Why?
|
| Armadillo Domain Proteins | 1 | 2013 | 23 | 0.410 |
Why?
|
| Myelin Proteins | 2 | 2024 | 30 | 0.410 |
Why?
|
| Protein Aggregates | 2 | 2024 | 20 | 0.410 |
Why?
|
| Myelin Sheath | 2 | 2024 | 37 | 0.410 |
Why?
|
| Spermatogenesis | 1 | 2013 | 69 | 0.410 |
Why?
|
| Genes, Dominant | 2 | 2010 | 57 | 0.400 |
Why?
|
| Luminescent Proteins | 3 | 2008 | 128 | 0.390 |
Why?
|
| Frontotemporal Lobar Degeneration | 1 | 2012 | 20 | 0.390 |
Why?
|
| Green Fluorescent Proteins | 7 | 2017 | 364 | 0.380 |
Why?
|
| Drosophila melanogaster | 3 | 2013 | 492 | 0.360 |
Why?
|
| MicroRNAs | 6 | 2014 | 674 | 0.360 |
Why?
|
| Genetic Vectors | 4 | 2011 | 871 | 0.350 |
Why?
|
| Central Nervous System | 4 | 2014 | 197 | 0.320 |
Why?
|
| Animals, Genetically Modified | 4 | 2014 | 290 | 0.310 |
Why?
|
| Disease Progression | 4 | 2022 | 1166 | 0.310 |
Why?
|
| Adenoviridae | 1 | 2009 | 121 | 0.300 |
Why?
|
| Molecular Chaperones | 2 | 2007 | 99 | 0.290 |
Why?
|
| Humans | 27 | 2024 | 63152 | 0.280 |
Why?
|
| Mitochondrial Diseases | 2 | 2004 | 22 | 0.270 |
Why?
|
| Fluorescent Dyes | 1 | 2008 | 198 | 0.270 |
Why?
|
| Membrane Proteins | 1 | 2013 | 894 | 0.260 |
Why?
|
| Electron Transport | 2 | 2002 | 36 | 0.250 |
Why?
|
| Transfection | 4 | 2011 | 690 | 0.240 |
Why?
|
| Base Sequence | 6 | 2011 | 1329 | 0.240 |
Why?
|
| Models, Genetic | 1 | 2006 | 260 | 0.230 |
Why?
|
| RNA, Small Nuclear | 1 | 2003 | 25 | 0.210 |
Why?
|
| Protein-Arginine Deiminases | 1 | 2024 | 86 | 0.210 |
Why?
|
| Intracellular Membranes | 1 | 2003 | 50 | 0.210 |
Why?
|
| Hydrolases | 1 | 2024 | 82 | 0.200 |
Why?
|
| Spastin | 1 | 2022 | 4 | 0.200 |
Why?
|
| Pick Disease of the Brain | 1 | 2022 | 6 | 0.200 |
Why?
|
| Spastic Paraplegia, Hereditary | 1 | 2022 | 10 | 0.200 |
Why?
|
| Single-Domain Antibodies | 1 | 2022 | 18 | 0.200 |
Why?
|
| Cell Line | 5 | 2008 | 2036 | 0.190 |
Why?
|
| Endosomal Sorting Complexes Required for Transport | 1 | 2022 | 57 | 0.190 |
Why?
|
| Immunohistochemistry | 3 | 2016 | 892 | 0.190 |
Why?
|
| Dendrites | 1 | 2002 | 56 | 0.190 |
Why?
|
| Histocytochemistry | 1 | 2002 | 47 | 0.190 |
Why?
|
| RNA | 1 | 2006 | 422 | 0.190 |
Why?
|
| Alleles | 3 | 2012 | 447 | 0.190 |
Why?
|
| Axons | 2 | 2012 | 123 | 0.190 |
Why?
|
| Motor Neuron Disease | 1 | 2002 | 28 | 0.190 |
Why?
|
| Molecular Sequence Data | 5 | 2012 | 1989 | 0.180 |
Why?
|
| Gene Knockdown Techniques | 2 | 2013 | 201 | 0.180 |
Why?
|
| Research Design | 1 | 2005 | 573 | 0.180 |
Why?
|
| Blotting, Western | 3 | 2011 | 607 | 0.180 |
Why?
|
| Peripheral Nerves | 1 | 2001 | 34 | 0.170 |
Why?
|
| Frontotemporal Dementia | 1 | 2022 | 149 | 0.170 |
Why?
|
| RNA, Messenger | 4 | 2010 | 1536 | 0.160 |
Why?
|
| Nucleic Acid Conformation | 3 | 2006 | 239 | 0.160 |
Why?
|
| Gene Expression Regulation, Enzymologic | 3 | 2006 | 131 | 0.160 |
Why?
|
| Proteins | 1 | 2024 | 751 | 0.140 |
Why?
|
| Cloning, Molecular | 2 | 2010 | 382 | 0.140 |
Why?
|
| Blotting, Northern | 2 | 2011 | 150 | 0.140 |
Why?
|
| Polymerase Chain Reaction | 2 | 2011 | 517 | 0.140 |
Why?
|
| Transduction, Genetic | 2 | 2017 | 237 | 0.140 |
Why?
|
| Mutant Proteins | 3 | 2013 | 105 | 0.140 |
Why?
|
| Introns | 2 | 2008 | 111 | 0.130 |
Why?
|
| 3' Untranslated Regions | 2 | 2008 | 94 | 0.130 |
Why?
|
| Paralysis | 1 | 2016 | 17 | 0.130 |
Why?
|
| Protein Aggregation, Pathological | 1 | 2016 | 19 | 0.130 |
Why?
|
| Muscular Atrophy | 1 | 2016 | 26 | 0.130 |
Why?
|
| Gene Dosage | 1 | 2016 | 65 | 0.130 |
Why?
|
| Cytoskeleton | 1 | 2016 | 138 | 0.120 |
Why?
|
| Gene Transfer Techniques | 2 | 2011 | 321 | 0.120 |
Why?
|
| Mice, Knockout | 3 | 2006 | 2107 | 0.120 |
Why?
|
| Lidocaine | 1 | 2015 | 33 | 0.120 |
Why?
|
| Injections | 1 | 2015 | 81 | 0.120 |
Why?
|
| Punctures | 1 | 2015 | 64 | 0.120 |
Why?
|
| Organ Specificity | 1 | 2015 | 193 | 0.110 |
Why?
|
| Behavior, Animal | 1 | 2016 | 230 | 0.110 |
Why?
|
| Mice, Inbred C57BL | 4 | 2017 | 3387 | 0.110 |
Why?
|
| Meiosis | 1 | 2013 | 65 | 0.100 |
Why?
|
| Down-Regulation | 2 | 2006 | 319 | 0.100 |
Why?
|
| Biomarkers | 3 | 2022 | 1393 | 0.100 |
Why?
|
| Infertility, Male | 1 | 2013 | 57 | 0.100 |
Why?
|
| Gene Expression | 1 | 2016 | 837 | 0.100 |
Why?
|
| Antibody Specificity | 1 | 2013 | 102 | 0.100 |
Why?
|
| Tissue Distribution | 1 | 2013 | 293 | 0.100 |
Why?
|
| Microscopy, Immunoelectron | 2 | 2003 | 31 | 0.100 |
Why?
|
| Testis | 1 | 2013 | 144 | 0.100 |
Why?
|
| Electron Transport Complex IV | 2 | 2002 | 14 | 0.100 |
Why?
|
| HEK293 Cells | 2 | 2013 | 618 | 0.100 |
Why?
|
| Epitopes | 1 | 2013 | 289 | 0.090 |
Why?
|
| Vesicular Transport Proteins | 1 | 2013 | 113 | 0.090 |
Why?
|
| HeLa Cells | 2 | 2011 | 535 | 0.090 |
Why?
|
| Reverse Transcription | 1 | 2011 | 8 | 0.090 |
Why?
|
| Blood-Brain Barrier | 1 | 2011 | 85 | 0.090 |
Why?
|
| Astrocytes | 1 | 2011 | 119 | 0.080 |
Why?
|
| Cells, Cultured | 4 | 2012 | 2152 | 0.080 |
Why?
|
| Exons | 1 | 2010 | 199 | 0.080 |
Why?
|
| RNA Splicing | 1 | 2010 | 162 | 0.080 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2011 | 542 | 0.080 |
Why?
|
| Gene Targeting | 2 | 2006 | 77 | 0.080 |
Why?
|
| Protein Structure, Tertiary | 1 | 2010 | 670 | 0.080 |
Why?
|
| Ketoglutarate Dehydrogenase Complex | 1 | 2008 | 1 | 0.080 |
Why?
|
| Protein-Lysine 6-Oxidase | 1 | 2008 | 4 | 0.080 |
Why?
|
| Cell Line, Tumor | 2 | 2010 | 1461 | 0.080 |
Why?
|
| Antibodies, Monoclonal | 1 | 2013 | 862 | 0.070 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2008 | 35 | 0.070 |
Why?
|
| Inflammation | 1 | 2015 | 1144 | 0.070 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 2007 | 46 | 0.070 |
Why?
|
| Neuroblastoma | 1 | 2007 | 52 | 0.070 |
Why?
|
| RNA Stability | 1 | 2008 | 102 | 0.070 |
Why?
|
| Computer-Aided Design | 1 | 2006 | 28 | 0.060 |
Why?
|
| DNA Polymerase II | 1 | 2006 | 8 | 0.060 |
Why?
|
| Tetracycline | 1 | 2006 | 24 | 0.060 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 2006 | 112 | 0.060 |
Why?
|
| Parkinson Disease | 1 | 2008 | 130 | 0.060 |
Why?
|
| DNA Polymerase III | 1 | 2006 | 28 | 0.060 |
Why?
|
| Nucleotides | 1 | 2006 | 48 | 0.060 |
Why?
|
| S-Nitrosothiols | 1 | 2006 | 3 | 0.060 |
Why?
|
| Luciferases | 1 | 2006 | 107 | 0.060 |
Why?
|
| Ovum | 1 | 2006 | 63 | 0.060 |
Why?
|
| Embryo, Mammalian | 1 | 2006 | 156 | 0.060 |
Why?
|
| Plasmids | 1 | 2006 | 291 | 0.060 |
Why?
|
| Fertilization | 1 | 2006 | 81 | 0.060 |
Why?
|
| Ubiquitin C | 1 | 2005 | 2 | 0.060 |
Why?
|
| DNA Primers | 1 | 2006 | 291 | 0.060 |
Why?
|
| Cell Differentiation | 1 | 2010 | 1348 | 0.060 |
Why?
|
| Embryonic Stem Cells | 1 | 2006 | 157 | 0.060 |
Why?
|
| Nerve Tissue Proteins | 1 | 2007 | 424 | 0.060 |
Why?
|
| Chronic Disease | 1 | 2008 | 752 | 0.060 |
Why?
|
| Microscopy, Fluorescence | 1 | 2006 | 400 | 0.060 |
Why?
|
| Survival Rate | 1 | 2006 | 846 | 0.050 |
Why?
|
| RNA-Binding Proteins | 1 | 2007 | 433 | 0.050 |
Why?
|
| RNA Polymerase III | 1 | 2003 | 10 | 0.050 |
Why?
|
| RNA, Antisense | 1 | 2003 | 51 | 0.050 |
Why?
|
| Drosophila | 2 | 2022 | 434 | 0.050 |
Why?
|
| RNA-Induced Silencing Complex | 1 | 2003 | 67 | 0.050 |
Why?
|
| Female | 4 | 2013 | 32709 | 0.050 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2005 | 489 | 0.050 |
Why?
|
| Neuronal Outgrowth | 1 | 2022 | 10 | 0.050 |
Why?
|
| Macromolecular Substances | 1 | 2003 | 160 | 0.050 |
Why?
|
| Electron Transport Complex II | 1 | 2002 | 3 | 0.050 |
Why?
|
| NADH, NADPH Oxidoreductases | 1 | 2002 | 18 | 0.050 |
Why?
|
| Spectrophotometry | 1 | 2002 | 35 | 0.050 |
Why?
|
| Point Mutation | 1 | 2003 | 166 | 0.050 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2003 | 107 | 0.050 |
Why?
|
| Succinate Dehydrogenase | 1 | 2002 | 15 | 0.050 |
Why?
|
| Electron Transport Complex I | 1 | 2002 | 15 | 0.050 |
Why?
|
| RNA, Untranslated | 1 | 2003 | 103 | 0.050 |
Why?
|
| Cytomegalovirus | 1 | 2003 | 91 | 0.050 |
Why?
|
| Oxidoreductases | 1 | 2002 | 64 | 0.050 |
Why?
|
| Multienzyme Complexes | 1 | 2002 | 81 | 0.050 |
Why?
|
| Anterior Horn Cells | 1 | 2002 | 6 | 0.050 |
Why?
|
| Tetanus Toxoid | 1 | 2022 | 14 | 0.050 |
Why?
|
| Posterior Horn Cells | 1 | 2002 | 6 | 0.050 |
Why?
|
| Kidney | 1 | 2005 | 444 | 0.050 |
Why?
|
| Apoptosis | 1 | 2007 | 1073 | 0.050 |
Why?
|
| Microscopy, Electron | 1 | 2002 | 250 | 0.050 |
Why?
|
| Male | 4 | 2014 | 29717 | 0.050 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2002 | 233 | 0.050 |
Why?
|
| Gene Expression Regulation | 1 | 2008 | 1614 | 0.050 |
Why?
|
| Protein Subunits | 1 | 2002 | 166 | 0.050 |
Why?
|
| Amino Acid Substitution | 1 | 2002 | 240 | 0.040 |
Why?
|
| Sulfur Radioisotopes | 1 | 2001 | 12 | 0.040 |
Why?
|
| Protein Folding | 1 | 2022 | 266 | 0.040 |
Why?
|
| Alzheimer Disease | 1 | 2008 | 721 | 0.040 |
Why?
|
| Methionine | 1 | 2001 | 55 | 0.040 |
Why?
|
| Tubulin | 1 | 2001 | 73 | 0.040 |
Why?
|
| Genotype | 1 | 2002 | 664 | 0.040 |
Why?
|
| Protein Conformation | 2 | 2013 | 777 | 0.040 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 2 | 2013 | 264 | 0.040 |
Why?
|
| Adenomatous Polyposis Coli Protein | 1 | 2017 | 8 | 0.040 |
Why?
|
| Ganglia, Spinal | 1 | 2017 | 30 | 0.030 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2017 | 40 | 0.030 |
Why?
|
| Injections, Spinal | 1 | 2017 | 46 | 0.030 |
Why?
|
| Calcium-Binding Proteins | 1 | 2017 | 92 | 0.030 |
Why?
|
| Microfilament Proteins | 1 | 2017 | 111 | 0.030 |
Why?
|
| Body Weight | 1 | 2017 | 377 | 0.030 |
Why?
|
| Treatment Outcome | 1 | 2006 | 5625 | 0.030 |
Why?
|
| Base Pair Mismatch | 2 | 2006 | 36 | 0.030 |
Why?
|
| Base Pairing | 2 | 2006 | 45 | 0.030 |
Why?
|
| Callithrix | 1 | 2014 | 21 | 0.030 |
Why?
|
| Primates | 1 | 2014 | 51 | 0.030 |
Why?
|
| Antibody Affinity | 1 | 2013 | 19 | 0.030 |
Why?
|
| Time Factors | 1 | 2001 | 3754 | 0.030 |
Why?
|
| Immunoprecipitation | 1 | 2013 | 126 | 0.030 |
Why?
|
| Jews | 1 | 2012 | 9 | 0.020 |
Why?
|
| Growth Cones | 1 | 2012 | 14 | 0.020 |
Why?
|
| Exome | 1 | 2012 | 77 | 0.020 |
Why?
|
| Pedigree | 1 | 2012 | 193 | 0.020 |
Why?
|
| Ubiquitination | 1 | 2012 | 111 | 0.020 |
Why?
|
| Actins | 1 | 2012 | 259 | 0.020 |
Why?
|
| Animals, Newborn | 1 | 2011 | 236 | 0.020 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2012 | 312 | 0.020 |
Why?
|
| Amino Acid Sequence | 1 | 2012 | 1591 | 0.020 |
Why?
|
| Protein Binding | 1 | 2013 | 1600 | 0.020 |
Why?
|
| Models, Molecular | 1 | 2012 | 1146 | 0.020 |
Why?
|
| SMN Complex Proteins | 1 | 2007 | 6 | 0.020 |
Why?
|
| Survival of Motor Neuron 1 Protein | 1 | 2007 | 7 | 0.020 |
Why?
|
| Cytoprotection | 1 | 2007 | 18 | 0.020 |
Why?
|
| Cell-Free System | 1 | 2006 | 31 | 0.020 |
Why?
|
| Base Composition | 1 | 2006 | 30 | 0.020 |
Why?
|
| Purines | 1 | 2006 | 42 | 0.020 |
Why?
|
| Microarray Analysis | 1 | 2006 | 64 | 0.020 |
Why?
|
| S-Nitrosoglutathione | 1 | 2006 | 1 | 0.020 |
Why?
|
| Glyceraldehyde-3-Phosphate Dehydrogenase (Phosphorylating) | 1 | 2006 | 4 | 0.020 |
Why?
|
| Nitrogen | 1 | 2006 | 26 | 0.020 |
Why?
|
| Embryo, Nonmammalian | 1 | 2006 | 178 | 0.020 |
Why?
|
| Cell Survival | 1 | 2007 | 568 | 0.020 |
Why?
|
| Dithiothreitol | 1 | 2005 | 18 | 0.020 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2006 | 114 | 0.020 |
Why?
|
| Brain | 1 | 2014 | 1553 | 0.010 |
Why?
|
| Copper | 1 | 2006 | 51 | 0.010 |
Why?
|
| Adenosine Diphosphate | 1 | 2003 | 42 | 0.010 |
Why?
|
| Hydrogen Bonding | 1 | 2003 | 129 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2006 | 1143 | 0.010 |
Why?
|
| RNA, Double-Stranded | 1 | 2003 | 111 | 0.010 |
Why?
|
| RNA Helicases | 1 | 2003 | 92 | 0.010 |
Why?
|
| Cell Nucleus | 1 | 2006 | 625 | 0.010 |
Why?
|
| Adenosine Triphosphate | 1 | 2003 | 293 | 0.010 |
Why?
|
| Kinetics | 1 | 2003 | 760 | 0.010 |
Why?
|
| Phosphorylation | 1 | 2003 | 937 | 0.010 |
Why?
|
| Models, Biological | 1 | 2003 | 1176 | 0.010 |
Why?
|